Urokinase mutant with better fibrin-specificity

Area of Science:

• Biochemistry and Molecular Biology
• Thrombolysis and Fibrinolysis Research

Background:

• Single-chain urokinase-type plasminogen activator (scu-PA) is a key enzyme in fibrinolysis.
• Understanding structure-function relationships is crucial for developing targeted thrombolytic agents.

Purpose of the Study:

• To investigate the impact of a specific amino acid deletion (150-156) on the enzymatic and fibrinolytic properties of scu-PA.
• To compare the fibrinolytic activity and specificity of the deleted mutant (dscu-PA) with its wild-type counterpart (rscu-PA).

Main Methods:

• Expression of recombinant wild-type (rscu-PA) and deleted (dscu-PA) forms in Escherichia coli.
• Purification using IgG affinity chromatography.
• Enzymatic activity assessment via synthetic substrate hydrolysis and in vitro fibrin clot/sepharose lysis assays.
• Analysis of fibrinogen concentration in plasma.

Main Results:

• The deletion of amino acids 150-156 did not impair the catalytic active site of dscu-PA.
• dscu-PA exhibited significantly higher fibrinolytic activity compared to rtcu-PA and rscu-PA.
• dscu-PA demonstrated minimal impact on plasma fibrinogen concentration, indicating enhanced fibrin specificity.

Conclusions:

• The 150-156 amino acid deletion enhances the fibrinolytic efficacy and specificity of scu-PA.
• Mutational strategies can be employed to improve the fibrin specificity of tcu-PA for therapeutic applications.
• dscu-PA represents a promising candidate for more targeted and effective thrombolytic therapy.